| 000 | 01455 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250517015513.0 | ||
| 264 | 0 | _c20160111 | |
| 008 | 201601s 0 0 eng d | ||
| 022 | _a1791-3004 | ||
| 024 | 7 |
_a10.3892/mmr.2015.3355 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHan, Xiujun | |
| 245 | 0 | 0 |
_aSynergistic combination of histone deacetylase inhibitor suberoylanilide hydroxamic acid and oncolytic adenovirus ZD55-TRAIL as a therapy against cervical cancer. _h[electronic resource] |
| 260 |
_bMolecular medicine reports _cJul 2015 |
||
| 300 |
_a435-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenoviridae _xgenetics |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHeLa Cells |
| 650 | 0 | 4 |
_aHistone Deacetylase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxamic Acids _xadministration & dosage |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aOncolytic Virotherapy |
| 650 | 0 | 4 |
_aUterine Cervical Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aVorinostat |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aWang, Shibing | |
| 700 | 1 | _aZhou, Wenjing | |
| 700 | 1 | _aLi, Ying | |
| 700 | 1 | _aLei, Wen | |
| 700 | 1 | _aLv, Weiguo | |
| 773 | 0 |
_tMolecular medicine reports _gvol. 12 _gno. 1 _gp. 435-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3892/mmr.2015.3355 _zAvailable from publisher's website |
| 999 |
_c24626267 _d24626267 |
||